Skip to main content
logo
Applied Therapeutics, Inc. (APLT)
Feb 3, 2026 - APLT was delisted (reason: acquired by Cycle Pharmaceuticals)
0.1030
0.00 (0.00%)
Inactive · Last trade price on Feb 2, 2026

Applied Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
1610025937235495
Market Cap Growth
-78.25%-61.49%608.34%-84.43%-52.60%-2.00%
Enterprise Value
63223-8129382
Last Close Price
0.100.863.350.768.9522.01

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
14.93218.9625.89---
PB Ratio
-1.75-15.098.993.756.04
P/TBV Ratio
-1.75-8.993.756.04

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
6.266.0022.27---

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
-4.460.05-0.040.370.030.03
Asset Turnover
0.010.010.21---
Quick Ratio
0.872.910.700.923.074.58
Current Ratio
0.963.060.761.123.344.83
Return on Equity (ROE)
-680.47%-529.98%--247.77%-146.16%-164.06%
Return on Assets (ROA)
-88.35%-92.12%-86.56%-80.84%-67.91%-77.23%
Return on Capital Employed (ROCE)
-6767.10%-175.60%394.70%-1679.50%-166.50%-113.40%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-115.50%-106.02%-46.29%-225.90%-45.00%-18.98%
Buyback Yield / Dilution
-10.63%-65.63%-122.72%-47.77%-16.53%-71.19%
SEC Filings: 10-K · 10-Q